The blog post linked by semi-infinite looks pretty comprehensive. I get it that Mr. Rushton is peeved that he and the co-authors of a similar study held back on publishing their results due to some of the same considerations he claims the authors of the Stanford study got wrong. However, given there are so many other sero-prevalence studies in the works, this study is probably useful to get people thinking about the issues involved.
Market Data 
Markets 
AI
